A Study of DM001 in Patients With Advanced Solid Tumors
A Study of DM001 in Patients With Advanced Solid Tumors
Active, not recruiting · NCT06475937 · Registry updated 2026-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of DM001 in Patients With Advanced Solid Tumors | Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder | Active, not recruiting | Phase 1 | 2026-08-28 | NCT06475937 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xadcera Biopharmaceutical (Suzhou) Co., Ltd. | 2 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Icon Cancer Centre South Brisbane | South Brisbane | Australia | 9 |
| Monash Health | Clayton | Australia | 74 |
| Sarah Cannon Research Institute (SCRI) | Nashville | United States | 7 |
| Tasman Oncology Research | Southport | Australia | 8 |
| University of Texas MD Anderson Cancer Center | Houston | United States | 192 |